Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling

Carcinogenesis

Volumn 34, Issue 7, 2013, Pages 1601-1610

  Li, Yonggang ^a   Zhang, Jingru ^a   Zhang, Lei ^a   Si, Meng ^a   Yin, Han ^a   Li, Jianmin ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIALLYL TRISULFIDE; GELATINASE A; GELATINASE B; MICRORNA; MICRORNA 143; MICRORNA 145; MICRORNA 200B; MICRORNA 200C; MICRORNA 34A; NOTCH1 RECEPTOR; TRANSCRIPTION FACTOR HES 1; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER GROWTH; CELL INVASION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MIGRATION; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; WOUND HEALING;

ALLYL COMPOUNDS; ANTINEOPLASTIC AGENTS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; COLLAGEN; CULTURE MEDIA, CONDITIONED; DRUG COMBINATIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LAMININ; MATRIX METALLOPROTEINASE 2; MICRORNAS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; OSTEOSARCOMA; PROTEOGLYCANS; RECEPTOR, NOTCH1; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SULFIDES; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84880320805     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt065     Document Type: Article

References (57)

1. Wu, P.K. et al. (2009) Primary osteogenic sarcoma with pulmonary metastasis:clinical results and prognostic factors in 91 patients. Jpn. J. Clin. Oncol., 39, 514-522.
2. Petrilli, A.S. et al.; Brazilian Osteosarcoma Treatment Group Studies IIIand IV. (2006) Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival. J. Clin. Oncol., 24, 1161-1168.
3. Tanaka, M. et al. (2009) Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation. Br. J. Cancer, 100, 1957-1965.
4. Zhang, P. et al. (2008) Critical role of notch signaling in osteosarcoma invasion and metastasis. Clin. Cancer Res., 14, 2962-2969.
5. Androutsellis-Theotokis, A. et al. (2006) Notch signalling regulates stem cell numbers in vitro and in vivo. Nature, 442, 823-826.
6. Ninov, N. et al. (2012) Different levels of Notch signaling regulate quiescence, renewal and differentiation in pancreatic endocrine progenitors. Development, 139, 1557-1567.
7. Maliekal, T.T. et al. (2008) The role of Notch signaling in human cervical cancer: implications for solid tumors. Oncogene, 27, 5110-5114.
8. Sonoshita, M. et al. (2011) Suppression of colon cancer metastasis by Aes through inhibition of Notch signaling. Cancer Cell, 19, 125-137.
9. Engin, F. et al. (2009) Notch signaling contributes to the pathogenesis of human osteosarcomas. Hum. Mol. Genet., 18, 1464-1470.
10. Hughes, D.P. (2009) How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize. Cancer Treat. Res., 152, 479-496.
11. Wang, Z. et al. (2010) Cross-talk between miRNA and Notch signaling pathways in tumor development and progression. Cancer Lett., 292, 141-148.
12. Denli, A.M. et al. (2004) Processing of primary microRNAs by the microprocessor complex. Nature, 432, 231-235.
13. Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
14. Esquela-Kerscher, A. et al. (2006) Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259-269.
15. Ziyan, W. et al. (2011) MicroRNA-21 is involved in osteosarcoma cell invasion and migration. Med. Oncol., 28, 1469-1474.
16. Fan, L. et al. (2012) MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells. Acta Biochim. Biophys. Sin. (Shanghai), 44, 407-414.
17. Osaki, M. et al. (2011) MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. Mol. Ther., 19, 1123-1130.
18. Yan, K. et al. (2012) MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo. PLoS ONE, 7, e33778.
19. de Antonellis, P. et al. (2011) MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma. PLoS ONE, 6, e24584.
20. Li, Y. et al. (2009) MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res., 69, 7569-7576.
21. Rivlin, R.S. (2001) Historical perspective on the use of garlic. J. Nutr., 131(3s), 951S-954S.
22. Shukla, Y. et al. (2007) Cancer chemoprevention with garlic and its constituents. Cancer Lett., 247, 167-181.
23. Powolny, A.A. et al. (2008) Multitargeted prevention and therapy of cancer by diallyl trisulfide and related Allium vegetable-derived organosulfur compounds. Cancer Lett., 269, 305-314.
24. Xiao, D. et al. (2004) Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2. Oncogene, 23, 5594-5606.
25. Xiao, D. et al. (2005) Diallyl trisulfide-induced G(2)-M phase cell cycle arrest in human prostate cancer cells is caused by reactive oxygen speciesdependent destruction and hyperphosphorylation of Cdc 25 C. Oncogene, 23, 6256-6268.
26. Seki, T. et al. (2008) Anticancer effects of diallyl trisulfide derived from garlic. Asia Pac. J. Clin. Nutr., 17 (suppl. 1), 249-252.
27. Zhang, Y.K. et al. (2009) A proteomic study on a human osteosarcoma cell line Saos-2 treated with diallyl trisulfide. Anticancer. Drugs, 20, 702-712.
28. Li, J. et al. (2009) Diallyl trisulfide reverses drug resistance and lowers the ratio of CD133+ cells in conjunction with methotrexate in a human osteosarcoma drug-resistant cell subline. Mol. Med. Report., 2, 245-252.
29. Xiao, D. et al. (2006) Diallyl trisulfide inhibits angiogenic features of human umbilical vein endothelial cells by causing Akt inactivation and down-regulation of VEGF and VEGF-R2. Nutr. Cancer, 55, 94-107.
30. Meyer, K. et al. (2004) Influence of organosulphur compounds from garlic on the secretion of matrix metalloproteinases and their inhibitor TIMP-1 by cultured HUVEC cells. Cell Biol. Toxicol., 20, 253-260.
31. Bao, B. et al. (2012) Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. Cancer Res., 72, 335-345.
32. Zhang, K. et al. (2008) Activation of RON differentially regulates claudin expression and localization: role of claudin-1 in RON-mediated epithelial cell motility. Carcinogenesis, 29, 552-559.
33. Li, Y. et al. (2010) miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res., 70, 1486-1495.
34. Wang, Z. et al. (2007) Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res., 67, 8293-8300.
35. Grammas, P. et al. (2011) Brain microvasculature and hypoxia-related proteins in Alzheimer's disease. Int. J. Clin. Exp. Pathol., 4, 616-627.
36. Leow, P.C. et al. (2010) Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/ß-catenin antagonists against human osteosarcoma cells. Invest. New Drugs, 28, 766-782.
37. Li, Y. et al. (2012) Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling. FEBS J., 279, 2247-2259.
38. Sweeney, T.E. et al. (2010) Differential regulation of the PGC family of genes in a mouse model of Staphylococcus aureus sepsis. PLoS ONE, 5, e11606.
39. Du, R. et al. (2012) Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells. PLoS ONE, 7, e30771.
40. Garg, P. et al. (2011) Notch1 regulates the effects of matrix metalloproteinase- 9 on colitis-associated cancer in mice. Gastroenterology, 141, 1381-1392.
41. Funahashi, Y. et al. (2011) Notch modulates VEGF action in endothelial cells by inducing matrix metalloprotease activity. Vasc. Cell, 3, 2.
42. Wang, Z. et al. (2006) Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res., 66, 2778-2784.
43. Curran, S. et al. (2000) Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur. J. Cancer, 36, 1621-1630.
44. Loges, S. et al. (2009) Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited. Cancer Cell, 15, 167-170.
45. Kobayashi, E. et al. (2012) MicroRNA involvement in osteosarcoma. Sarcoma, 2012, 359739.
46. Jones, K.B. et al. (2012) miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res., 72, 1865-1877.
47. Schetter, A.J. et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA, 299, 425-436.
48. Kang, H.G. et al. (2007) RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness. J. Orthop. Res., 25, 696-702.
49. Bao, B. et al. (2011) Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett., 307, 26-36.
50. Boucher, J.M. et al. (2011) The miR-143/145 cluster is a novel transcriptional target of Jagged-1/Notch signaling in vascular smooth muscle cells. J. Biol. Chem., 286, 28312-28321.
51. Zhang, H. et al. (2010) microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol. Rep., 24, 1363-1369.
52. He, C. et al. (2009) Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples. Biochem. Biophys. Res. Commun., 388, 35-40.
53. Kato, M. et al. (2009) The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells. Oncogene, 28, 2419-2424.
54. Ji, Q. et al. (2009) MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS ONE, 4, e6816.
55. Kong, D. et al. (2009) miR-200 regulates PDGF-D-mediated epithelialmesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells, 27, 1712-1721.
56. Li, Y. et al. (2009) Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine- resistant pancreatic cancer cells. Cancer Res., 69, 6704-6712.
57. Zhang, B. et al. (2007) microRNAs as oncogenes and tumor suppressors. Dev. Biol., 302, 1-12.